Several tests in cultured cells indicated that ganciclovir would cause the death of HSV - TK - expressing stem cells, and testing in the mouse model confirmed that administration of the drug after successful
treatment of brain metastases successfully eliminated therapeutic stem cells that also expressed HSV - TK.
Not exact matches
«Viable
treatment options for
brain metastases are still an unmet need,» said Hong Zhao, M.D., Ph.D., assistant professor
of systems medicine and bioengineering at Houston Methodist Research Institute and co-corresponding author.
«We found genetic alterations in
brain metastases that could affect
treatment decisions in more than half
of the patients in our study,» Dr Brastianos will say.
Approximately eight to ten percent
of cancer patients will develop
brain metastases, and
treatment options are limited.
«Genetic screening
of brain metastases could reveal new targets for
treatment.»
Thus, based on the robust findings from the current study and until proven otherwise, WBRT may still have an important role for
treatment of patients who are not in this specific disease category (i.e., 1 - 3
brain metastases).
Whole
brain radiotherapy (WBRT) significantly improves tumor control in the
brain after SRS, yet because
of its association with cognitive decline, its role in the
treatment of patients with
brain metastases remains controversial.
While neither a drug that targets HER3 nor one that interferes with the interaction between HER2 and HER3 were able to slow the growth
of brain metastases, combined
treatment with both an anti-HER2 and an anti-HER3 drug significantly slowed tumor growth.
After confirming in mouse models that cells from HER2 - positive breast cancers became resistant to anti-HER2
treatment when implanted into the
brain but not into other tissues, the investigators found that HER3 is overexpressed in
brain metastases of HER2 - positive breast cancers from both mice and human patients.
«Stem - cell - based therapy promising for
treatment of breast cancer
metastases in the
brain.»
Faculty in the
Brain and Spinal Tumor Program focus on clinical research and treatment of primary brain tumors, neoplastic meningitis, brain metastases, epidural cord compression, neurotoxicities, anticancer agents, and cancer pain manage
Brain and Spinal Tumor Program focus on clinical research and
treatment of primary
brain tumors, neoplastic meningitis, brain metastases, epidural cord compression, neurotoxicities, anticancer agents, and cancer pain manage
brain tumors, neoplastic meningitis,
brain metastases, epidural cord compression, neurotoxicities, anticancer agents, and cancer pain manage
brain metastases, epidural cord compression, neurotoxicities, anticancer agents, and cancer pain management.
Undergoing immunotherapy within a month
of stereotactic radiosurgery resulted in an improved response to
treatment for patients with melanoma
brain metastases.
Dr. Anders, a native
of Burlington, N.C., an assistant professor in the University
of North Carolina at Chapel Hill School
of Medicine and a member
of the UNC Lineberger Comprehensive Cancer Center, was chosen for her work on the identification
of the prognosis and
treatment of breast cancer
brain metastases.